Pharmaceutical

Genentech to onshore US manufacturing amid rising drug pricing tensions

Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North Carolina.

May 24, 2025 - 06:00
Genentech to onshore US manufacturing amid rising drug pricing tensions
Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North Carolina.
Read the original article

Tags:

Previous Article

Proteins Essential for Healthy Brain Development Captured on Film

Next Article

ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bionomics to advance non-SSRI PTSD candidate to Phase III

Bionomics to advance non-SSRI PTSD candidate to Phase III

Mar 22, 2024

STAT+: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million

STAT+: Six months after launch, Bert Vogelstein’s lates...

Apr 27, 2023

STAT+: Novartis drug reduces breast cancer recurrence, but experts may debate results

STAT+: Novartis drug reduces breast cancer recurrence, ...

Jun 2, 2023